Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampligen in HIV Strategic Therapeutic Intervention
NCT00035893Phase 2Completed
- Sponsor
- AIM ImmunoTech
- Start
- May 2001
- Primary completion
- Aug 2006
- Countries
- 1
01
Overview
A Phase 2 trial of rintatolimod in human immunodeficiency virus infection (HIV), sponsored by AIM ImmunoTech. Started May 2001; status: completed.
02
Drugs
rintatolimod
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00035893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035893.